German Pharma Stock News

XTRA:AFX
XTRA:AFXMedical Equipment

Is Carl Zeiss Meditec (XTRA:AFX) Offering Opportunity After A 52% One Year Share Price Slump

If you are wondering whether Carl Zeiss Meditec is starting to look like value after a tough run, this article will walk you through what the current share price might be implying. The stock has faced heavy pressure, with returns of a 1.7% decline over 7 days, a 6.4% decline over 30 days, a 33.0% decline year to date and a 52.4% decline over 1 year, plus a 78.4% decline over 3 years and 77.8% over 5 years. Recent coverage has focused on the company as a key player in medical technology and...
XTRA:SHL
XTRA:SHLMedical Equipment

Is Siemens Healthineers (XTRA:SHL) Now Attractive After A 22% One Year Share Price Fall

If you are wondering whether Siemens Healthineers is attractively priced at its current level, this article walks through what the numbers suggest and how that might matter for your portfolio. The stock last closed at €41.55, with returns of 1.5% over 7 days, a 4.0% decline over 30 days, a 5.9% decline year to date and a 21.9% decline over 1 year. These moves may catch the eye of investors weighing potential upside against recent share price pressure. Recent news flow around Siemens...
XTRA:TMV
XTRA:TMVSoftware

Assessing TeamViewer (XTRA:TMV) Valuation After Mixed 2025 Earnings And Updated Analyst Ratings

TeamViewer (XTRA:TMV) is back in focus after its fourth quarter and full year 2025 earnings, with higher sales but lower full year net profit, alongside refreshed analyst coverage and ratings. See our latest analysis for TeamViewer. The mixed earnings picture and renewed analyst coverage come against a weak share price backdrop, with a 30 day share price return showing a 16.56% decline and a 1 year total shareholder return of 61.75% decline, suggesting sentiment has cooled even as revenue has...
XTRA:VBK
XTRA:VBKOil and Gas

Will Record Output and Narrowed Losses Reshape Verbio's (XTRA:VBK) Profitability Narrative?

Verbio SE has reported past second-quarter 2025 results showing sales of €456.52 million and net income of €3.38 million, alongside higher first-half sales of €896.22 million and a sharply reduced net loss of €0.663 million compared with the prior year. Alongside these financials, Verbio delivered record production volumes in Europe, with higher ethanol and biomethane output underpinned by improved uptime at key U.S. plants and the ramp-up of new facilities. We’ll now examine how Verbio’s...
XTRA:DFTK
XTRA:DFTKDiversified Financial

Assessing DF Deutsche Forfait (XTRA:DFTK) Valuation After Intraday Price Surge And Pre Earnings Trading Spike

Why DF Deutsche Forfait (XTRA:DFTK) just jumped onto traders’ radar DF Deutsche Forfait (XTRA:DFTK) drew attention after a sharp intraday price surge on 16 February 2026, accompanied by heavy trading volume ahead of its scheduled earnings announcement on 28 April 2026. See our latest analysis for DF Deutsche Forfait. That sudden jump in trading interest sits on top of a very strong run, with the share price at €8.15 and multi month share price returns many times higher than earlier levels,...
XTRA:KWS
XTRA:KWSFood

A Look At KWS SAAT SE KGaA (XTRA:KWS) Valuation After Mixed Half Year Earnings Results

KWS SAAT SE KGaA (XTRA:KWS) reported second quarter sales of €183.1 million and a net loss of €54 million, with a wider half year loss despite broadly stable sales, sharpening focus on earnings quality. See our latest analysis for KWS SAAT SE KGaA. The earnings update lands after a choppy spell for the shares, with a 7 day share price return of a 10.96% decline and a 30 day share price return of a 10.59% decline, even though the 1 year total shareholder return is 20.59%. This suggests longer...
XTRA:HTG
XTRA:HTGHospitality

European Penny Stocks To Watch In February 2026

As European markets navigate volatility, with the STOXX Europe 600 Index reaching new highs yet remaining relatively unchanged, investors are keenly observing potential opportunities amid AI disruption concerns. For those interested in smaller or newer companies, penny stocks—despite their outdated moniker—continue to present intriguing prospects for growth at lower price points. By focusing on stocks with strong financials and solid fundamentals, investors can uncover hidden gems that may...
DB:AWK
DB:AWKPharmaceuticals

3 European Stocks Estimated To Be Trading Up To 48.2% Below Intrinsic Value

As European markets navigate a landscape marked by volatility and concerns over AI disruption, the pan-European STOXX Europe 600 Index recently reached a new high before settling with modest gains. Amidst these fluctuations, identifying stocks trading below their intrinsic value can offer potential opportunities for investors seeking to capitalize on market inefficiencies.
XTRA:DBK
XTRA:DBKCapital Markets

Deutsche Bank Settlement Begins Clearing Monte Dei Paschi Overhang For Investors

Deutsche Bank has reached a confidential settlement with former manager Stefano Foresti in a lawsuit tied to the Monte dei Paschi accounting scandal. The agreement concludes the first of several related cases brought by former employees over their alleged involvement in the affair. The outcome may influence how remaining internal disputes linked to the scandal are handled. For you as an investor looking at XTRA:DBK, this legal development comes with the share price at €29.6. The stock has...
XTRA:NDX1
XTRA:NDX1Electrical

What Nordex (XTRA:NDX1)'s New 220 MW European Orders Mean For Shareholders

In early February 2026, Nordex SE reported new European onshore wind orders totaling 220 MW across the UK, Turkiye, Lithuania and Sweden, all bundled with multi-year service and maintenance agreements that aim to secure long-term turbine performance in both standard and cold-climate sites. These contracts highlight Nordex’s growing strength in cold-climate and community wind projects, where its anti-icing technology and long-duration service deals are becoming central to how it competes for...
XTRA:NCH2
XTRA:NCH2Construction

A Look At Thyssenkrupp Nucera (XTRA:NCH2) Valuation After Q1 Loss And Middle East Electrolyzer Win

Earnings and contract wins set the tone for investors thyssenkrupp nucera KGaA (XTRA:NCH2) has drawn attention after first quarter earnings showed lower sales and a small net loss, while management reiterated full year guidance and announced a large electrolyzer contract in the Middle East. See our latest analysis for thyssenkrupp nucera KGaA. At a share price of €9.37, the stock has a 1-day share price return of 2.69% and a 90-day share price return of 12.22%. The 1-year total shareholder...